Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer

Abstract

Tracking large numbers of individualized tumor mutations in cfDNA can improve MRD detection, but its sensitivity is driven by the number of tumor mutations available to track.